<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7171518\results\search\disease\results.xml">
  <result pre="Elsevier Ltd. pmcid: 7171518S2052-2975(20)30031-7 doi: 10.1016/j.nmni.2020.100679100679 : Article Novel coronavirus" exact="disease" post="(COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics) HamidSaima1MirMohammad"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="as the COVID-19 resource centre remains active. Abstract The coronavirus" exact="disease" post="(COVID-19) is highly pathogenic viral infection caused by SARS-CoV-2."/>
  <result pre="remains active. Abstract The coronavirus disease (COVID-19) is highly pathogenic" exact="viral infection" post="caused by SARS-CoV-2. Currently, COVID-19 has caused global health"/>
  <result pre="active. Abstract The coronavirus disease (COVID-19) is highly pathogenic viral" exact="infection" post="caused by SARS-CoV-2. Currently, COVID-19 has caused global health"/>
  <result pre="has revealed that SARS-CoV-2 has significant sequence similarity with severe" exact="acute" post="respiratory syndrome-like (SARS-like) bat viruses, thus bats could be"/>
  <result pre="revealed that SARS-CoV-2 has significant sequence similarity with severe acute" exact="respiratory" post="syndrome-like (SARS-like) bat viruses, thus bats could be primary"/>
  <result pre="acute respiratory syndrome-like (SARS-like) bat viruses, thus bats could be" exact="primary" post="possible reservoir. The intermediate host and there subsequent transfer"/>
  <result pre="bat viruses, thus bats could be primary possible reservoir. The" exact="intermediate" post="host and there subsequent transfer is not known yet,"/>
  <result pre="to human transfer is widely confirmed. The transmission of COVID-19" exact="infection" post="from one person to another resulted in the isolation"/>
  <result pre="taken around the globe to reduce the transmission of COVID-19" exact="infection" post="particularly banning international and domestic flights, inducting lockdowns in"/>
  <result pre="clinical trials, few broad-spectrum antiviral drugs were evaluated against COVID-19" exact="infection" post="which resulted in clinical recovery. In this article emergence"/>
  <result pre="clinical recovery. In this article emergence and pathogenicity of COVID-19" exact="infection" post="along with potential therapeutic strategies are analyzed to combat"/>
  <result pre="one of the major pathogens which targets primarily the human" exact="respiratory" post="system. Earlier coronaviral outbreaks (CoVs) include Middle East respiratory"/>
  <result pre="human respiratory system. Earlier coronaviral outbreaks (CoVs) include Middle East" exact="respiratory" post="syndrome (MERS)-CoV and severe acute respiratory syndrome (SARS)-CoV which"/>
  <result pre="respiratory system. Earlier coronaviral outbreaks (CoVs) include Middle East respiratory" exact="syndrome" post="(MERS)-CoV and severe acute respiratory syndrome (SARS)-CoV which have"/>
  <result pre="outbreaks (CoVs) include Middle East respiratory syndrome (MERS)-CoV and severe" exact="acute" post="respiratory syndrome (SARS)-CoV which have significantly caused great threat"/>
  <result pre="(CoVs) include Middle East respiratory syndrome (MERS)-CoV and severe acute" exact="respiratory" post="syndrome (SARS)-CoV which have significantly caused great threat to"/>
  <result pre="include Middle East respiratory syndrome (MERS)-CoV and severe acute respiratory" exact="syndrome" post="(SARS)-CoV which have significantly caused great threat to human"/>
  <result pre="3.58 [3]. In December 2019 the first cases for COVID-19" exact="infections" post="were reported [4]. From 18th December, 2029 to 29th"/>
  <result pre="18th December, 2029 to 29th December 2019, 5 patients having" exact="acute" post="respiratory distress syndrome were hospitalized among which one patient"/>
  <result pre="December, 2029 to 29th December 2019, 5 patients having acute" exact="respiratory" post="distress syndrome were hospitalized among which one patient died"/>
  <result pre="to 29th December 2019, 5 patients having acute respiratory distress" exact="syndrome" post="were hospitalized among which one patient died [5]. Upto"/>
  <result pre="infection. Almost half of these patients had underlying diseases particularly" exact="cardiovascular" post="diseases, hypertension and diabetes [6]. It was believed that"/>
  <result pre="half of these patients had underlying diseases particularly cardiovascular diseases," exact="hypertension" post="and diabetes [6]. It was believed that these patients"/>
  <result pre="these patients had underlying diseases particularly cardiovascular diseases, hypertension and" exact="diabetes" post="[6]. It was believed that these patients were infected"/>
  <result pre="that these patients were infected in hospital possibly due to" exact="nosocomial infection." post="Thus it was concluded COVID-19 is not a super-hot"/>
  <result pre="patients who were infected. As of January 22, 2020 a" exact="total" post="of 571 COVID-19 infection cases were reported in 25"/>
  <result pre="As of January 22, 2020 a total of 571 COVID-19" exact="infection" post="cases were reported in 25 provinces of China [7]."/>
  <result pre="details of first 17 deaths. On 25th January 2020 a" exact="total" post="of 1975 COVID-19 infection cases were confirmed along with"/>
  <result pre="deaths. On 25th January 2020 a total of 1975 COVID-19" exact="infection" post="cases were confirmed along with 56 deaths in mainland"/>
  <result pre="[8]. Another report of 24th January 2020, estimated 5502 COVID-19" exact="infections" post="in China [9,10]. The first COVID-19 infection case was"/>
  <result pre="estimated 5502 COVID-19 infections in China [9,10]. The first COVID-19" exact="infection" post="case was reported on 10th January 2020 which was"/>
  <result pre="included initial mild symptoms of the patient which leaded to" exact="pneumonia" post="on 9th day of illness [11]. Moreover on 30"/>
  <result pre="transmission was reported in US (https://www.cdc.gov/media/releases/2020/p0130). Until 5th April 2020," exact="total" post="number of COVID-19 infected cases in USA mounted to"/>
  <result pre="Chinese health authorities concluded that 31,161 people had contracted the" exact="infection" post="in China as of 7 February 2019, and that"/>
  <result pre="and that more than 630 people had died of the" exact="infection" post="(http://www.natur.com/articles/d41586-020-00154). On 5th April 2020, total number of infected"/>
  <result pre="had died of the infection (http://www.natur.com/articles/d41586-020-00154). On 5th April 2020," exact="total" post="number of infected cases in Italy has reached to"/>
  <result pre="active. Out of these 15,362 are death cases (https://www.worldometers.info/coronavirus/). Currently" exact="total" post="number of corona virus cases in India reported so"/>
  <result pre="April, 2020 is represented in Fig.Â 1 . Fig.Â 1" exact="Total" post="confirmed cases of COVID-19 per million people around the"/>
  <result pre="as on 4th April, 2020 (European CDC). Symptoms The COVID-19" exact="infection" post="symptoms starts to appear after an incubation period of"/>
  <result pre="years patients [8]. The common symptoms at the onset of" exact="infection" post="are fatigue, cough and fever while as other symptoms"/>
  <result pre="as other symptoms include lymphopenia, haemoptysis, headache, sputum production and" exact="diarrhea" post="[13]. The chest CT scan reveals pneumonia nevertheless there"/>
  <result pre="include lymphopenia, haemoptysis, headache, sputum production and diarrhea [13]. The" exact="chest" post="CT scan reveals pneumonia nevertheless there are some other"/>
  <result pre="sputum production and diarrhea [13]. The chest CT scan reveals" exact="pneumonia" post="nevertheless there are some other clinical features like acute"/>
  <result pre="reveals pneumonia nevertheless there are some other clinical features like" exact="acute" post="cardiac injury, acute respiratory distress syndrome, RNAaemia and incidence"/>
  <result pre="there are some other clinical features like acute cardiac injury," exact="acute" post="respiratory distress syndrome, RNAaemia and incidence of grand-glass opacities"/>
  <result pre="are some other clinical features like acute cardiac injury, acute" exact="respiratory" post="distress syndrome, RNAaemia and incidence of grand-glass opacities that"/>
  <result pre="opacities that leads to death [6]. In certain cases, several" exact="peripheral" post="ground-glass opacities have been identified in subpleural regions of"/>
  <result pre="in subpleural regions of both lungs which likely induce both" exact="localized" post="and systemic immune response leading to increased inflammation [14]."/>
  <result pre="regions of both lungs which likely induce both localized and" exact="systemic" post="immune response leading to increased inflammation [14]. Unfortunately interferon"/>
  <result pre="no therapeutic benefit but instead aggravated the disorder by worsening" exact="pulmonary" post="opacity [14]. It is pertinent to mention here that"/>
  <result pre="is pertinent to mention here that symptoms between earlier betacoronavirus" exact="infections" post="and COVID-19 such as bilateral ground-glass opacity on CT"/>
  <result pre="that symptoms between earlier betacoronavirus infections and COVID-19 such as" exact="bilateral" post="ground-glass opacity on CT scans, dry cough, dyspnea and"/>
  <result pre="More importantly, COVID-19 showed unique clinical features like targeting the" exact="lower" post="airway as is evident by symptoms like sore throat,"/>
  <result pre="throat, rhinorrhoea and sneezing [15,16]. Additionally, on the basis of" exact="chest" post="radiographs results some cases were found to possess infiltrate"/>
  <result pre="results some cases were found to possess infiltrate in the" exact="upper" post="lobe of the lung associated with increasing dyspnea with"/>
  <result pre="manage the disease. Epidemiology The first four cases of an" exact="acute" post="respiratory syndrome of unknown etiology were identified among people"/>
  <result pre="the disease. Epidemiology The first four cases of an acute" exact="respiratory" post="syndrome of unknown etiology were identified among people linked"/>
  <result pre="disease. Epidemiology The first four cases of an acute respiratory" exact="syndrome" post="of unknown etiology were identified among people linked to"/>
  <result pre="[19]. Eventually human-to-human transmission by close contact was found as" exact="secondary" post="cause of COVID-19 infection. There has been rise in"/>
  <result pre="of wildlife exposure or visiting Wuhan and several cases of" exact="infection" post="have been identified among medical professionals as well [20]."/>
  <result pre="professionals as well [20]. It has become apparent that COVID-19" exact="infection" post="occurs upon exposure to virus and both normal and"/>
  <result pre="and both normal and immunosuppressed population seem susceptible. Most of" exact="adult" post="patients were between 35 -55 years of age with"/>
  <result pre="the TableÂ 1 . TableÂ 1 Epidemiological indicators of COVID-19" exact="infection" post="TableÂ 1 Indicators Description Patient age Cases ranged between"/>
  <result pre="Elderly people [8] People with poor immune function People with" exact="chronic" post="co-morbidities [8] Surgery history before admission [8] Pathogenesis and"/>
  <result pre="fluid nine inpatients were enrolled by researchers in Wuhan with" exact="viral pneumonia" post="and without any common respiratory pathogens. The results indicated"/>
  <result pre="nine inpatients were enrolled by researchers in Wuhan with viral" exact="pneumonia" post="and without any common respiratory pathogens. The results indicated"/>
  <result pre="researchers in Wuhan with viral pneumonia and without any common" exact="respiratory" post="pathogens. The results indicated SARS-CoV-2 was more distinct from"/>
  <result pre="of SARS-CoV [32,33]. The case fatality rate (CFR) of any" exact="disease" post="is not fixed it varies with location and with"/>
  <result pre="testing is applied between the countries or many cases are" exact="symptomatic" post="vs asymptomatic. So for better decision making and to"/>
  <result pre="in Fig.Â 2 . Fig.Â 2 The growth kinetics COVID-19" exact="infection" post="in different countries around the globe as on 4th"/>
  <result pre="Efforts were made to look for a host reservoir or" exact="intermediate" post="carriers from which the infection could spread to humans"/>
  <result pre="for a host reservoir or intermediate carriers from which the" exact="infection" post="could spread to humans [10]. The two snake species"/>
  <result pre="analysis showed its 88 % identity with two bat-derived severe" exact="acute" post="respiratory syndrome (SARS)-like coronaviruses suggesting that bats are the"/>
  <result pre="showed its 88 % identity with two bat-derived severe acute" exact="respiratory" post="syndrome (SARS)-like coronaviruses suggesting that bats are the most"/>
  <result pre="its 88 % identity with two bat-derived severe acute respiratory" exact="syndrome" post="(SARS)-like coronaviruses suggesting that bats are the most likely"/>
  <result pre="from person to person is a possible way for COVID-19" exact="infection" post="to spread. As it was observed COVID-19 infection occurred"/>
  <result pre="for COVID-19 infection to spread. As it was observed COVID-19" exact="infection" post="occurred in many people who did not even visited"/>
  <result pre="not even visited Wuhan's wet animal market [13]. Transmission of" exact="disease" post="from person to person occurs mainly through direct contact"/>
  <result pre="through coughing or sneezing. The Fig.Â 3 how quickly the" exact="disease" post="has spread in each country since the 100th confirmed"/>
  <result pre="is important as pregnant women's are comparatively more vulnerable to" exact="respiratory" post="infections and extreme pneumonia [34]. The first step of"/>
  <result pre="important as pregnant women's are comparatively more vulnerable to respiratory" exact="infections" post="and extreme pneumonia [34]. The first step of COVID-19"/>
  <result pre="women's are comparatively more vulnerable to respiratory infections and extreme" exact="pneumonia" post="[34]. The first step of COVID-19 viral infection is"/>
  <result pre="infections and extreme pneumonia [34]. The first step of COVID-19" exact="viral infection" post="is the binding of the receptor expressed by host"/>
  <result pre="and extreme pneumonia [34]. The first step of COVID-19 viral" exact="infection" post="is the binding of the receptor expressed by host"/>
  <result pre="cells followed by fusion with the cell membrane. The lung" exact="epithelial" post="cells are the primary target of the virus. It"/>
  <result pre="with the cell membrane. The lung epithelial cells are the" exact="primary" post="target of the virus. It has been stated that"/>
  <result pre="animal species there by implicating these animal species are possible" exact="intermediate" post="hosts or animal models for COVID-19 infections [35]. Additionally"/>
  <result pre="species are possible intermediate hosts or animal models for COVID-19" exact="infections" post="[35]. Additionally these viruses have single intact open reading"/>
  <result pre="use the same receptor [5]. Clinical manifestation and diagnosis The" exact="complete" post="clinical manifestation is not yet clear, as the symptoms"/>
  <result pre="death [18]. The most frequently reported symptoms include cough-producing phlegm," exact="runny nose," post="myalgia, fever, pneumonia, and complicated dyspnea, while the less"/>
  <result pre="as severe cases have been reported to suffer from progressive" exact="respiratory" post="failure due to alveolar damage which can lead to"/>
  <result pre="patients and middle aged patients with some pre-existing diseases (coronary" exact="heart" post="disease, Parkinson's disease, diabetes, hypertension, tumor surgery and cirrhosis)"/>
  <result pre="middle aged patients with some pre-existing diseases (coronary heart disease," exact="Parkinson's disease," post="diabetes, hypertension, tumor surgery and cirrhosis) were seen to"/>
  <result pre="some pre-existing diseases (coronary heart disease, Parkinson's disease, diabetes, hypertension," exact="tumor" post="surgery and cirrhosis) were seen to more prone to"/>
  <result pre="decrease in lymphocytes and white blood cells, fever and new" exact="pulmonary" post="infiltrates on chest radiography with no improvement in symptoms"/>
  <result pre="and white blood cells, fever and new pulmonary infiltrates on" exact="chest" post="radiography with no improvement in symptoms after 3 days"/>
  <result pre="detect SARS-CoV-2 positive nucleic acid in sputum, throat swabs, and" exact="lower" post="respiratory tract sample secretions [39]. Therapeutics options There is"/>
  <result pre="SARS-CoV-2 positive nucleic acid in sputum, throat swabs, and lower" exact="respiratory" post="tract sample secretions [39]. Therapeutics options There is no"/>
  <result pre="is specific antiviral treatment recommended so far. The treatment is" exact="symptomatic" post="and the patients with severe infection are given oxygen"/>
  <result pre="far. The treatment is symptomatic and the patients with severe" exact="infection" post="are given oxygen therapy. In cases of respiratory failure"/>
  <result pre="with severe infection are given oxygen therapy. In cases of" exact="respiratory" post="failure mechanical ventilation is required whereas hemodynamic support is"/>
  <result pre="mechanical ventilation is required whereas hemodynamic support is important for" exact="septic shock" post="management. The WHO on 28th January, 2020 released a"/>
  <result pre="address steps for identification and sorting of patients with serious" exact="acute" post="respiratory disease, guidelines for laboratory diagnosis, early supportive therapy"/>
  <result pre="steps for identification and sorting of patients with serious acute" exact="respiratory" post="disease, guidelines for laboratory diagnosis, early supportive therapy and"/>
  <result pre="for laboratory diagnosis, early supportive therapy and monitoring, management of" exact="septic shock" post="and respiratory failure and methods of treatment for pregnant"/>
  <result pre="early supportive therapy and monitoring, management of septic shock and" exact="respiratory" post="failure and methods of treatment for pregnant patients. Amongst"/>
  <result pre="patients. Amongst these recommendations, we focus on approaches to tackle" exact="respiratory" post="failure, including safe mechanical ventilation and non-invasive ventilation (NIV)"/>
  <result pre="ventilation balloon and the mask. In case of mechanical ventilation" exact="lower" post="inspiratory pressures, reaching a plateau pressure (Pplat)Â 2O and"/>
  <result pre="lower inspiratory pressures, reaching a plateau pressure (Pplat)Â 2O and" exact="lower" post="tidal volumes (4 to 6 ml/kg predicted body weight,"/>
  <result pre="as low as possible (&amp;lt;14 cm H2O). Furthermore to prevent" exact="atelectasis" post="and loss of PEEP disconnections from the ventilator must"/>
  <result pre="ventilation for &amp;gt;12 hours per day for patients suffering from" exact="acute" post="respiratory distress syndrome is strongly recommended. Non-invasive ventilation With"/>
  <result pre="for &amp;gt;12 hours per day for patients suffering from acute" exact="respiratory" post="distress syndrome is strongly recommended. Non-invasive ventilation With regard"/>
  <result pre="hours per day for patients suffering from acute respiratory distress" exact="syndrome" post="is strongly recommended. Non-invasive ventilation With regard to high"/>
  <result pre="ventilation can be used only in non severe forms of" exact="respiratory" post="failure. Nevertheless, if the patient does not improve or"/>
  <result pre="the patient does not improve or even worsen within a" exact="limited" post="period of time (1â€&quot;2 hours) the mechanical ventilation must"/>
  <result pre="interferons-Î± nebulization and anti-viral drugs were used to reduce the" exact="viral" post="load [41] but only remdesivir has shown promising viral"/>
  <result pre="the viral load [41] but only remdesivir has shown promising" exact="viral" post="impact [42]. Remdesivir alone and in combination with chloroquine"/>
  <result pre="Nitazoxanide, Ribavirin, Baricitinib, Penciclovir, Ritonavir and Arbidol when tested against" exact="infection" post="inÂ vitro clinical isolates and in patients [44]. Many"/>
  <result pre="[44]. Many other formulations have also been tested against COVID-19" exact="infections" post="in humans and mice such as combinations of antibiotic"/>
  <result pre="strain of SARS-CoV (AY278741) and there by significantly reduced the" exact="viral infection" post="in animal models [[49], [50], [51]]. Numerous other SARS-CoV"/>
  <result pre="of SARS-CoV (AY278741) and there by significantly reduced the viral" exact="infection" post="in animal models [[49], [50], [51]]. Numerous other SARS-CoV"/>
  <result pre="develop inactivated or live-vectored vaccines that have effectively reduced the" exact="viral" post="load in animal models. These strains include BJ01 (AY278488)"/>
  <result pre="few vaccines against SARS-CoV-2 in pipeline. The Chinese Centre for" exact="Disease" post="Control and Prevention (CDC) is focusing on creating an"/>
  <result pre="other vaccines. For instance vaccines for other diseases like for" exact="measles" post="and rubella can create cross-resistance for SARS-CoV-2. This concept"/>
  <result pre="For instance vaccines for other diseases like for measles and" exact="rubella" post="can create cross-resistance for SARS-CoV-2. This concept of cross"/>
  <result pre="on the findings that children are found less vulnerable to" exact="infection" post="as compared to elder population and children predominantly vaccinated"/>
  <result pre="announcementâ€� which officially included COVID-19 in the management of legally" exact="infectious diseases" post="in Class B and allowed for class A infectious"/>
  <result pre="infectious diseases in Class B and allowed for class A" exact="infectious disease" post="preventive and control measures to be implemented [64]. Under"/>
  <result pre="diseases in Class B and allowed for class A infectious" exact="disease" post="preventive and control measures to be implemented [64]. Under"/>
  <result pre="issued national guidelines on the prevention and control of COVID-19" exact="infection" post="on 22 January 2020 for medical institutes to prevent"/>
  <result pre="infection on 22 January 2020 for medical institutes to prevent" exact="nosocomial infection" post="[65]. On 28 January 2020, during the Chinese Spring"/>
  <result pre="on 22 January 2020 for medical institutes to prevent nosocomial" exact="infection" post="[65]. On 28 January 2020, during the Chinese Spring"/>
  <result pre="and control measures to effectively contain the spread of the" exact="disease" post="through a &quot;major isolation and great disinfectionâ€� program [66]."/>
  <result pre="to patients diagnosed with COVID-19, it was recommended that appropriate" exact="symptomatic" post="treatment and supportive care be applied [6]. The studies"/>
  <result pre="have also reported the prevention of psychological health issues and" exact="nosocomial infection" post="associated with COVID. A series of measures have been"/>
  <result pre="also reported the prevention of psychological health issues and nosocomial" exact="infection" post="associated with COVID. A series of measures have been"/>
  <result pre="COVID. A series of measures have been suggested to minimize" exact="nosocomial infection," post="including awareness training for prevention and control, isolation, disinfection,"/>
  <result pre="prevention and control, isolation, disinfection, protection at different levels in" exact="infection" post="areas and protection of reported cases [68]. With respect"/>
  <result pre="and other protections were discussed and suggested for protection. The" exact="infection" post="prevention and control measures that can minimize the risk"/>
  <result pre="safely disposed of, regular hand wash with soap or disinfection" exact="with hand" post="sanitizer having 60% alcohol in it, maintaining an appropriate"/>
  <result pre="or confirmed cases. As per these guidelines an individual without" exact="respiratory" post="symptoms when in public is not required to wear"/>
  <result pre="models play a crucial role in uncovering the mechanisms of" exact="viral" post="pathogenicity from the entrance to transmission and in the"/>
  <result pre="examining replication of SARS-CoV which showed the symptoms of severe" exact="infection" post="[73]. In case MERS-CoV no pathogenesis was observed in"/>
  <result pre="case of SARS-CoV. Mice was found not susceptible to MERS-coronavirus" exact="infection" post="because of noncompatibility of the DPP4 receptor [74]. As"/>
  <result pre="having a mutation for spike glycoprotein, replicate and cause severe" exact="disease" post="in Rats (F344) [75]. Thus spike glycoprotein targeting therapeutics"/>
  <result pre="outbreak requires rigorous steps to reduce the transmission of COVID-19" exact="infection" post="from person to person. Special attention and efforts should"/>
  <result pre="poor immune system that allows for more rapid progression of" exact="viral infection" post="[12]. The decontaminating regents should be provided by public"/>
  <result pre="immune system that allows for more rapid progression of viral" exact="infection" post="[12]. The decontaminating regents should be provided by public"/>
  <result pre="to control virus spread. The epidemiological changes occurring in COVID-19" exact="infection" post="should be monitored carefully taking into account potential transmission"/>
  <result pre="and subclinical infections, as well as the adaptation, evolution, possible" exact="intermediate" post="animals and reservoir and spread of virus among humans."/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 2LuH.StrattonC.W.TangY.W.Outbreak of pneumonia"/>
  <result pre="coronavirus pneumonia in Wuhan, China: a descriptive studyLancet395202050751332007143 2LuH.StrattonC.W.TangY.W.Outbreak of" exact="pneumonia" post="of unknown etiology in wuhan China: the mystery and"/>
  <result pre="coronavirusNat Rev Microbiol18202012310.1038/s41579-020-0332-031988490 5RenL.L.WangY.M.WuZ.Q.Identification of a novel coronavirus causing severe" exact="pneumonia" post="in human: a descriptive studyChin Med J202010.1097/CM9.0000000000000722 6HuangC.WangY.LiX.RenL.ZhaoJ.HuY.Clinical features"/>
  <result pre="demographic, and clinical characteristics of 47 cases of Middle East" exact="respiratory" post="syndrome coronavirus disease from Saudi Arabia: a descriptive studyLancet"/>
  <result pre="and clinical characteristics of 47 cases of Middle East respiratory" exact="syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
  <result pre="characteristics of 47 cases of Middle East respiratory syndrome coronavirus" exact="disease" post="from Saudi Arabia: a descriptive studyLancet Infect Dis13201375276123891402 16LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.M.AÂ"/>
  <result pre="a descriptive studyLancet Infect Dis13201375276123891402 16LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.M.AÂ major outbreak of severe" exact="acute" post="respiratory syndrome in Hong KongNÂ Engl J Med34820031986199412682352 17PhanL.T.NguyenT.V.LuongQ.C.NguyenT.V.Importation"/>
  <result pre="descriptive studyLancet Infect Dis13201375276123891402 16LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.M.AÂ major outbreak of severe acute" exact="respiratory" post="syndrome in Hong KongNÂ Engl J Med34820031986199412682352 17PhanL.T.NguyenT.V.LuongQ.C.NguyenT.V.Importation and"/>
  <result pre="studyLancet Infect Dis13201375276123891402 16LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.M.AÂ major outbreak of severe acute respiratory" exact="syndrome" post="in Hong KongNÂ Engl J Med34820031986199412682352 17PhanL.T.NguyenT.V.LuongQ.C.NguyenT.V.Importation and human-to-human"/>
  <result pre="of Tongji hospitalQuick guide to the diagnosis and treatment of" exact="pneumonia" post="for novel coronavirus infections3rd ed.2020Herald Medhttp://kns.cnki.net/kcms/detail/42.1293.r.20200130.1803.002.html 20GralinskiL.E.MenacheryV.D.Return of the"/>
  <result pre="coronavirus infections3rd ed.2020Herald Medhttp://kns.cnki.net/kcms/detail/42.1293.r.20200130.1803.002.html 20GralinskiL.E.MenacheryV.D.Return of the coronavirus: 2019-nCoVViruses122020135 21WangC.WangX.Prevalence," exact="nosocomial infection" post="and psychological prevention of novel coronavirus infectionChin Gen Pract"/>
  <result pre="infections3rd ed.2020Herald Medhttp://kns.cnki.net/kcms/detail/42.1293.r.20200130.1803.002.html 20GralinskiL.E.MenacheryV.D.Return of the coronavirus: 2019-nCoVViruses122020135 21WangC.WangX.Prevalence, nosocomial" exact="infection" post="and psychological prevention of novel coronavirus infectionChin Gen Pract"/>
  <result pre="2019 novel coronavirus (2019-nCoV)202010.1101/2020.01.25.919787 23ZhuN.ZhangD.WangW.LiX.YangB.SongJ.AÂ novel coronavirus from patients with" exact="pneumonia" post="in China, 2019NÂ Engl J Med202010.1056/NEJMoa2001017 24WHOCoronavirushttps://www.who.int/health-topics/coronavirus2020 25SuS.WongG.ShiW.LiuJ.LaiA.C.K.ZhouJ.Epidemiology, genetic"/>
  <result pre="Microbiol242016490502 26ChenY.LiuQ.GuoD.Coronaviruses: genome structure, replication, and pathogenesisJÂ Med Virol202010.1002/jmv.25681 27PeirisJ.S.GuanY.YuenK.Severe" exact="acute" post="respiratory syndromeNat Med102004S88S9715577937 28ZakiA.M.BoheemenS.V.BestebroerT.M.OsterhausA.D.M.E.FouchierR.A.M.Isolation of a novel coronavirus from"/>
  <result pre="26ChenY.LiuQ.GuoD.Coronaviruses: genome structure, replication, and pathogenesisJÂ Med Virol202010.1002/jmv.25681 27PeirisJ.S.GuanY.YuenK.Severe acute" exact="respiratory" post="syndromeNat Med102004S88S9715577937 28ZakiA.M.BoheemenS.V.BestebroerT.M.OsterhausA.D.M.E.FouchierR.A.M.Isolation of a novel coronavirus from a"/>
  <result pre="Med102004S88S9715577937 28ZakiA.M.BoheemenS.V.BestebroerT.M.OsterhausA.D.M.E.FouchierR.A.M.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaNÂ Engl J Med36720121814182023075143 29collab: Chinese Center"/>
  <result pre="in Saudi ArabiaNÂ Engl J Med36720121814182023075143 29collab: Chinese Center for" exact="Disease" post="Control and Prevention585 environmental samples from the south China"/>
  <result pre="China seafood market in wuhan, Hubei province, China2020http://www.chinacdc.cn/yw_9324/202001/t20200127_211469.html 30LuH.TangC.W.TangY.Outbreak of" exact="pneumonia" post="of unknown etiology in Wuhan China: the mystery and"/>
  <result pre="of Peopleâ€™s Republic of ChinaPneumonia diagnosis and treatment of 2019-nCoV" exact="infection" post="from Chinese NHC and CDC 2020http://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed352020 40HuiD.S.ChowB.K.LoT.TsangO.T.Y.KoF.W.NgS.S.GinT.ChanM.T.V.Exhaled air dispersion"/>
  <result pre="cytoplasmic RNA viruses to prevent cell deathCell Death Differ202012031745213 42AgostiniM.L.AndresE.L.SimsA.C.GrahamR.L.SheahanT.P.LuX.Coronavirus" exact="susceptibility to" post="the antiviral remdesivir (GS-5734) is mediated by the viral"/>
  <result pre="susceptibility to the antiviral remdesivir (GS-5734) is mediated by the" exact="viral" post="polymerase and the proofreading exoribonucleaseMBio922018e00221-18 43WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and chloroquine effectively"/>
  <result pre="(2019-nCoV) inÂ vitroCell Res20201331802008 44RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.Baricitinib as potential treatment for 2019-nCoV" exact="acute" post="respiratory diseaseThe Lancet2020 45SheahanT.P.SimsA.C.LeistS.R.SchÃ¤ferA.WonJ.BrownA.J.Comparative therapeutic efficacy of remdesivir and"/>
  <result pre="inÂ vitroCell Res20201331802008 44RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.Baricitinib as potential treatment for 2019-nCoV acute" exact="respiratory" post="diseaseThe Lancet2020 45SheahanT.P.SimsA.C.LeistS.R.SchÃ¤ferA.WonJ.BrownA.J.Comparative therapeutic efficacy of remdesivir and combination"/>
  <result pre="Medical Soc 47BishtH.RobertsA.VogelL.SubbaraoK.MossB.Neutralizing antibody and protective immunity to SARS coronavirus" exact="infection" post="of mice induced by a soluble recombinant polypeptide containing"/>
  <result pre="into B cells inÂ vitroVaccine254200772974017049691 49KapadiaS.U.RoseJ.K.LamirandeE.VogelL.SubbaraoK.RobertsA.Long-term protection from SARS coronavirus" exact="infection" post="conferred by a single immunization with an attenuated VSV-based"/>
  <result pre="by a single immunization with an attenuated VSV-based vaccineVirology3402200517418216043204 50BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.Severe" exact="acute" post="respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia"/>
  <result pre="a single immunization with an attenuated VSV-based vaccineVirology3402200517418216043204 50BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.Severe acute" exact="respiratory" post="syndrome coronavirus spike protein expressed by attenuated vaccinia virus"/>
  <result pre="single immunization with an attenuated VSV-based vaccineVirology3402200517418216043204 50BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.Severe acute respiratory" exact="syndrome" post="coronavirus spike protein expressed by attenuated vaccinia virus protectively"/>
  <result pre="50BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated" exact="vaccinia" post="virus protectively immunizes miceProc Natl Acad Sci1011720046641664615096611 51BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of"/>
  <result pre="Natl Acad Sci1011720046641664615096611 51BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the structural proteins of severe" exact="acute" post="respiratory syndrome coronavirus to protective immunityProc Natl Acad Sci1012620049804980915210961"/>
  <result pre="Acad Sci1011720046641664615096611 51BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the structural proteins of severe acute" exact="respiratory" post="syndrome coronavirus to protective immunityProc Natl Acad Sci1012620049804980915210961 52TangL.ZhuQ.QinE.YuM.DingZ.ShiH.Inactivated"/>
  <result pre="Sci1011720046641664615096611 51BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the structural proteins of severe acute respiratory" exact="syndrome" post="coronavirus to protective immunityProc Natl Acad Sci1012620049804980915210961 52TangL.ZhuQ.QinE.YuM.DingZ.ShiH.Inactivated SARS-CoV"/>
  <result pre="monkeys of purified inactivated Vero-cell SARS vaccineVaccine24720061028103416388880 54WeingartlH.CzubM.CzubS.NeufeldJ.MarszalP.GrenJ.Immunization with modified" exact="vaccinia" post="virus Ankara-based recombinant vaccine against severe acute respiratory syndrome"/>
  <result pre="54WeingartlH.CzubM.CzubS.NeufeldJ.MarszalP.GrenJ.Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe" exact="acute" post="respiratory syndrome is associated with enhanced hepatitis in ferretsJÂ"/>
  <result pre="with modified vaccinia virus Ankara-based recombinant vaccine against severe acute" exact="respiratory" post="syndrome is associated with enhanced hepatitis in ferretsJÂ Virol78222004126721267615507655"/>
  <result pre="modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory" exact="syndrome" post="is associated with enhanced hepatitis in ferretsJÂ Virol78222004126721267615507655 55SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.Comparative"/>
  <result pre="vaccine against severe acute respiratory syndrome is associated with enhanced" exact="hepatitis" post="in ferretsJÂ Virol78222004126721267615507655 55SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.Comparative evaluation of two severe acute"/>
  <result pre="enhanced hepatitis in ferretsJÂ Virol78222004126721267615507655 55SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.Comparative evaluation of two severe" exact="acute" post="respiratory syndrome (SARS) vaccine candidates in mice challenged with"/>
  <result pre="hepatitis in ferretsJÂ Virol78222004126721267615507655 55SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.Comparative evaluation of two severe acute" exact="respiratory" post="syndrome (SARS) vaccine candidates in mice challenged with SARS"/>
  <result pre="in ferretsJÂ Virol78222004126721267615507655 55SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.Comparative evaluation of two severe acute respiratory" exact="syndrome" post="(SARS) vaccine candidates in mice challenged with SARS coronavirusJÂ"/>
  <result pre="with novel coronavirus is included in the management of legal" exact="infectious" post="diseaseshttp://www.nhc.gov.cn/jkj/s7915/202001/e4e2d5e6 f01147e0a8df3f6701d49f33.shtml2020 65collab: National Health Commission of Peopleâ€™s Republic"/>
  <result pre="the technical guide for prevention and control of novel coronavirus" exact="infection" post="in medical institutions1st ed.2020http://www.nhc.gov.cn/yzygj/s7659/202001/b91fdab7c304431eb082d6784 7d27e14.shtml 66collab: National Health Commission"/>
  <result pre="and distributing the work plan for prevention and control of" exact="pneumonia" post="caused by novel coronavirus infection in the near futureAccessedhttp://www.nhc.gov.cn/tigs/s7848/202001/808bbf75e5ce415aa19f74c78ddc653f.shtml2020"/>
  <result pre="for prevention and control of pneumonia caused by novel coronavirus" exact="infection" post="in the near futureAccessedhttp://www.nhc.gov.cn/tigs/s7848/202001/808bbf75e5ce415aa19f74c78ddc653f.shtml2020 67collab: National Health Commission of"/>
  <result pre="Peopleâ€™s Republic of ChinaNotice on further prevention and control of" exact="pneumonia" post="caused by novel coronavirus infection in rural areasAccessedhttp://www.nhc.gov.cn/jkj/s3578/202001/f8d45f6af1d24ef18151c1d91cf8a028.shtml2020 68WeiQ.RenZ.Disinfection"/>
  <result pre="further prevention and control of pneumonia caused by novel coronavirus" exact="infection" post="in rural areasAccessedhttp://www.nhc.gov.cn/jkj/s3578/202001/f8d45f6af1d24ef18151c1d91cf8a028.shtml2020 68WeiQ.RenZ.Disinfection measures for pneumonia foci infected"/>
  <result pre="by novel coronavirus infection in rural areasAccessedhttp://www.nhc.gov.cn/jkj/s3578/202001/f8d45f6af1d24ef18151c1d91cf8a028.shtml2020 68WeiQ.RenZ.Disinfection measures for" exact="pneumonia" post="foci infected by novel coronavirus in 2019Chin J Disinfect3720205962"/>
  <result pre="first batch of clinical first-line support nurses to fight against" exact="pneumonia" post="caused by novel coronavirusChin Nurs Res34202013 70OuF.WuH.YangY.TanW.ZhangJ.GuJ.Countermeasures for rapid"/>
  <result pre="coronavirusChin Nurs Res34202013 70OuF.WuH.YangY.TanW.ZhangJ.GuJ.Countermeasures for rapid spread of new coronavirus" exact="pneumonia" post="in WuhanChin Gen Pract Nurs2020http://kns.cnki.net/kcms/detail/14.1349.R.20200131.1319.002.html 71WHOAdvice on the use"/>
  <result pre="peptidase 4 is not a functional receptor for Middle East" exact="respiratory" post="syndrome coronavirus infectionJÂ Virol88920145195519924574399 75NagataN.IwataN.HasegawaH.FukushiS.YokoyamaM.HarashimaA.Participation of both host and"/>
  <result pre="4 is not a functional receptor for Middle East respiratory" exact="syndrome" post="coronavirus infectionJÂ Virol88920145195519924574399 75NagataN.IwataN.HasegawaH.FukushiS.YokoyamaM.HarashimaA.Participation of both host and virus"/>
  <result pre="of both host and virus factors in induction of severe" exact="acute" post="respiratory syndrome (SARS) in F344 rats infected with SARS"/>
  <result pre="both host and virus factors in induction of severe acute" exact="respiratory" post="syndrome (SARS) in F344 rats infected with SARS coronavirusJÂ"/>
  <result pre="host and virus factors in induction of severe acute respiratory" exact="syndrome" post="(SARS) in F344 rats infected with SARS coronavirusJÂ Virol81420071848185717151094"/>
  <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version)Mil Med Res72020432029004"/>
 </snippets>
</snippetsTree>
